National differences in publishing papers on adverse drug reactions

Article date: January 2005

By: R. E. Ferner, J. K. Aronson, in Volume 59, Issue 1, pages 108-111

Aims

To examine how countries differ in attitudes to adverse drug reactions by examining published scientific papers.

Methods

We searched Ovid EMBASE for publications indexed by the category ′therapeutic agents′, and the subcategory ′adverse effects′, by country for 43 countries.

Results

We counted 1 810 202 papers world‐wide regarding therapeutic agents during 14 years, of which 195 154 (10.8%) were included in the adverse effects subcategory. There were substantial differences between countries, not explained by population, economic variation, overall publication rate on therapeutic agents, or the presence of large indigenous pharmaceutical companies.

Conclusions

Many local cultural factors influence the ratio of papers on adverse reactions to all drug effects, so it may be difficult to improve their recognition and reporting by international efforts.

DOI: 10.1111/j.1365-2125.2005.02267.x

View this article